Clinical Research Directory
Browse clinical research sites, groups, and studies.
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm
Sponsor: University of Alabama at Birmingham
Summary
This is a masked randomized clinical trial in which extremely preterm infants fed human milk will be randomly assigned to receive either the highest (intervention group) or lowest (control group) vitamin D dose recommended during the first 14 days after birth.
Official title: Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm: A Randomized Trial
Key Details
Gender
All
Age Range
1 Day - 4 Days
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2023-03-16
Completion Date
2026-05
Last Updated
2025-05-30
Healthy Volunteers
No
Conditions
Interventions
Vitamin D supplementation
Study participants assigned to the intervention group will receive 800 IU/ day of vitamin D plus 200-300 IU/day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.
No additional vitamin D supplementation
Study participants assigned to the control group will receive 200-300 IU/ day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States